Research
Adhering to the development principle of technological innovation.
Research Institute Scale and Structure
The SCBM Biopharmaceutical Innovation Research Institute spans approximately 4,300 square meters. Under the leadership of Director Ye Hejia, it comprises eight core technology platforms
- Influenza Technology Platform
- Genetic Engineering Technology Platform
- Cell Process Technology Platform
- Fermentation Process Technology Platform
- Process Innovation Technology Platform
- Diagnostic Center Technology Platform
- Laboratory Animal Registration Platform
- Product Registration Platform
These platforms comprehensively cover the entire R&D process for poultry, pet, and aquatic vaccines.
Specialized Laboratory Facilities
The institute is equipped with fully functional specialized laboratories, including:
- Clean Cell Culture Room
- Suspension Cell Engineering Laboratory
- Reverse Genetics Laboratory
- Genetic Engineering Laboratory
- Exogenous Virus Detection Room
- Microbiology Laboratory
- Fermentation Engineering Laboratory
- Emulsification Process Laboratory
- Molecular Biology Laboratory
These facilities fully meet the requirements for project development and pilot-scale testing.
Advanced Equipment Investment
- Automated Nucleic Acid Extraction Systems
- Fluorescent Quantitative PCR Instruments
- High-Speed Refrigerated Centrifuges
- Vacuum Freeze Dryers
- High-Shear Dispersion Homogenizers
- Fluorescence Microscopes
- Microplate Readers
- Purification Equipment
- Ultra-Low Temperature Incubators
- Viscometers
- CO? Incubators
Technological Advantages
The well-equipped laboratories and advanced instruments provide robust support for all R&D projects.
Through systematic platform development, specialized laboratory spaces, and cutting-edge equipment, the institute has established a comprehensive technology system covering the entire vaccine R&D process, ensuring efficient progress in technological innovation and product development.
